Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 124 active Myeloproliferative Neoplasms trials
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
Study Type: Interventional Phase 2
Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Study Type: Interventional Phase 2
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Study Type: Interventional Phase 3
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Study Type: Interventional Phase 2
Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
Study Type: Interventional Phase 3
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
Study Type: Interventional Phase 2
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Study Type: Interventional Phase 2
Myeloproliferative Neoplasms (MPN) and COVID-19
Study Type: Observational
There are 124 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now